← All votes
719 of 719 records
Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest
2026-01-20 · rejected · official record
Procedure: 2025/0102(COD) · amendment 259
Considérant 4 - Am 259
At a glance
The recorded outcome was rejected. Against led by 257 votes. The available roll call contains 719 MEP position records, including any recorded non-votes. This vote is linked to procedure 2025/0102(COD).
Source and coverage
- Source last checked
- 20/10/2026, 06:00:12
- Record current through
- 07/09/2026
- Institution
- European Parliament
- Parliamentary term
- Term 10
Coverage limitations: This page reports the stored roll call; it does not infer motives, attendance reasons, or unrecorded votes.
Read reporting and briefings ↗
For
197
Against
454
Abstention
7
Did not vote
61
How countries voted
Vote-time affiliation snapshots; no current-roster projection.
| Country | For | Against | Abstain | No vote |
|---|---|---|---|---|
| DEagainst +49 | 20 | 69 | 1 | 6 |
| FR | 36 | 36 | 0 | 9 |
| ITagainst +12 | 30 | 42 | 0 | 4 |
| ESagainst +37 | 8 | 45 | 0 | 7 |
| PLagainst +1 | 24 | 25 | 0 | 4 |
| ROagainst +20 | 5 | 25 | 0 | 3 |
| NLagainst +14 | 7 | 21 | 2 | 1 |
| BEagainst +10 | 4 | 14 | 0 | 4 |
| CZfor +7 | 13 | 6 | 0 | 2 |
| GRagainst +13 | 4 | 17 | 0 | 0 |
| HUfor +9 | 11 | 2 | 0 | 8 |
| PTagainst +16 | 1 | 17 | 0 | 3 |
| SEagainst +13 | 3 | 16 | 0 | 2 |
| ATagainst +8 | 6 | 14 | 0 | 0 |
| BGagainst +6 | 5 | 11 | 0 | 1 |
| DKagainst +10 | 2 | 12 | 0 | 1 |
| FIagainst +13 | 1 | 14 | 0 | 0 |
| SK | 5 | 5 | 4 | 1 |
| IEagainst +13 | 0 | 13 | 0 | 1 |
| HRagainst +11 | 0 | 11 | 0 | 1 |
| LTagainst +4 | 3 | 7 | 0 | 1 |
| LVagainst +1 | 4 | 5 | 0 | 0 |
| SIagainst +7 | 1 | 8 | 0 | 0 |
| EEagainst +5 | 1 | 6 | 0 | 0 |
| CYagainst +2 | 2 | 4 | 0 | 0 |
| LUagainst +4 | 1 | 5 | 0 | 0 |
| MTagainst +4 | 0 | 4 | 0 | 2 |
How political groups voted
Vote-time affiliation snapshots; no current-roster projection.
| Group | For | Against | Abstain | No vote |
|---|---|---|---|---|
| EPPagainst +158 | 7 | 165 | 2 | 14 |
| S&Dagainst +126 | 0 | 126 | 0 | 10 |
| PfEfor +78 | 78 | 0 | 0 | 7 |
| ECRfor +71 | 72 | 1 | 0 | 6 |
| Renewagainst +65 | 2 | 67 | 0 | 6 |
| Greens/EFAagainst +50 | 0 | 50 | 0 | 3 |
| The Leftagainst +38 | 0 | 38 | 0 | 8 |
| Non-attachedfor +7 | 14 | 7 | 5 | 4 |
| ESNfor +24 | 24 | 0 | 0 | 3 |
MEP roll call
Search and filter the recorded vote-time delegation.
Other votes in this procedure
2025/0102(COD) →- Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest2026-01-20 · main vote · rejected
- Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest2026-01-20 · main vote · adopted
- Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest2026-01-20 · amendment 178 · adopted
- Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest2026-01-20 · amendment 187 · adopted
- Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest2026-01-20 · amendment 162 · adopted
- Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest2026-01-20 · amendment 256 · adopted
- Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest2026-01-20 · amendment 247 · rejected
- Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest2026-01-20 · amendment 164 · adopted
Data via HowTheyVote.eu (Open Database License), compiled from official European Parliament sources.